Works matching IS 00278874 AND DT 2024 AND VI 116 AND IP 9
Results: 20
Correction to: Frameshift mutations in peripheral blood as a biomarker for surveillance of Lynch syndrome.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2024, v. 116, n. 9, p. 1535, doi. 10.1093/jnci/djae174
- Publication type:
- Article
Reviewers.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2024, v. 116, n. 9, p. 1536, doi. 10.1093/jnci/djae161
- Publication type:
- Article
RE: Is it time to reconsider the role of upfront cytoreductive nephrectomy in metastatic renal cell carcinoma?
- Published in:
- JNCI: Journal of the National Cancer Institute, 2024, v. 116, n. 9, p. 1534, doi. 10.1093/jnci/djae158
- By:
- Publication type:
- Article
The utility of value frameworks in cost communications: making them real for patients.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2024, v. 116, n. 9, p. 1411, doi. 10.1093/jnci/djae156
- By:
- Publication type:
- Article
Improving our understanding of the complex relationship between cancer-related cognitive decline and Alzheimer's disease.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2024, v. 116, n. 9, p. 1414, doi. 10.1093/jnci/djae146
- By:
- Publication type:
- Article
Stat Bite: Cancer of the Corpus and Uterus 5-Year Survival by Race and Ethnicity and Stage.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2024, v. 116, n. 9, p. 1540, doi. 10.1093/jnci/djae144
- Publication type:
- Article
Response to Wu and Zhang.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2024, v. 116, n. 9, p. 1532, doi. 10.1093/jnci/djae131
- By:
- Publication type:
- Article
RE: Spatial intratumor heterogeneity of programmed cell death ligand 1 expression predicts poor prognosis in resected non–small cell lung cancer.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2024, v. 116, n. 9, p. 1530, doi. 10.1093/jnci/djae130
- By:
- Publication type:
- Article
Future patterns in burden and incidence of squamous cell carcinoma of the anus in the United States, 2001-2035.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2024, v. 116, n. 9, p. 1508, doi. 10.1093/jnci/djae127
- By:
- Publication type:
- Article
Survivorship after adolescent and young adult cancer: models of care, disparities, and opportunities.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2024, v. 116, n. 9, p. 1417, doi. 10.1093/jnci/djae119
- By:
- Publication type:
- Article
Primary human papillomavirus testing vs cotesting: clinical outcomes in populations with different disease prevalence.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2024, v. 116, n. 9, p. 1525, doi. 10.1093/jnci/djae117
- By:
- Publication type:
- Article
Combining antivascular endothelial growth factor and anti-epidermal growth factor receptor antibodies: randomized phase II study of irinotecan and cetuximab with/without ramucirumab in second-line colorectal cancer (ECOG-ACRIN E7208).
- Published in:
- JNCI: Journal of the National Cancer Institute, 2024, v. 116, n. 9, p. 1487, doi. 10.1093/jnci/djae114
- By:
- Publication type:
- Article
Alzheimer disease–related biomarkers and cancer-related cognitive decline: the Thinking and Living with Cancer study.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2024, v. 116, n. 9, p. 1495, doi. 10.1093/jnci/djae113
- By:
- Publication type:
- Article
The association of body composition phenotypes before chemotherapy with epithelial ovarian cancer mortality.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2024, v. 116, n. 9, p. 1513, doi. 10.1093/jnci/djae112
- By:
- Publication type:
- Article
Health insurance among survivors of childhood cancer following Affordable Care Act implementation.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2024, v. 116, n. 9, p. 1466, doi. 10.1093/jnci/djae111
- By:
- Publication type:
- Article
Association between oral targeted cancer drug net health benefit, uptake, and spending.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2024, v. 116, n. 9, p. 1479, doi. 10.1093/jnci/djae110
- By:
- Publication type:
- Article
Ataxia telangiectasia and Rad3-related (ATR) inhibitor camonsertib dose optimization in patients with biomarker-selected advanced solid tumors (TRESR study).
- Published in:
- JNCI: Journal of the National Cancer Institute, 2024, v. 116, n. 9, p. 1439, doi. 10.1093/jnci/djae098
- By:
- Publication type:
- Article
Recent and projected incidence trends and risk of anal cancer among people with HIV in North America.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2024, v. 116, n. 9, p. 1450, doi. 10.1093/jnci/djae096
- By:
- Publication type:
- Article
Precision medicine for pancreatic cancer: characterizing the clinicogenomic landscape and outcomes of KRAS G12C-mutated disease.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2024, v. 116, n. 9, p. 1429, doi. 10.1093/jnci/djae095
- By:
- Publication type:
- Article
Prostate cancer incidence and mortality in men exposed to α1-adrenergic receptor antagonists.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2024, v. 116, n. 9, p. 1459, doi. 10.1093/jnci/djae108
- By:
- Publication type:
- Article